RedHill Biopharma Announces U.S. Commercialization Agreement for FDAApproved GI Product Esomeprazole Strontium DelayedRelease Capsules

RedHill was granted the exclusive rights to promote Esomeprazole Strontium DelayedRelease DR Capsules to gastroenterologists in certain U.S. territoriesEsomeprazole Strontium DR Capsules 49.3 mg is an FDAapproved proprietary prescription proton pump inhibi...